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AbstrACt
Objectives Dyslipidaemia is a metabolic disease 
influenced by environmental and genetic factors. 
Especially, family history related to genetic background 
is a strong risk factor of lipid abnormality. The aim of this 
study is to evaluate the association between the lipid 
profiles of adolescents and their mothers.
Design A cross-sectional study.
setting The data were derived from the Korea National 
Health and Nutrition Examination Survey (IV-VI) between 
2009 and 2015.
Participants 2884 adolescents aged 12–18 years and 
their mothers were included.
Primary outcome measures Outcome variables were 
adolescents’ lipid levels. Mothers’ lipid levels were the 
interesting variables. The lipid profiles included total 
cholesterol (TC), triglyceride (TG), high-density lipoprotein 
cholesterol (HDL-C) and low-density lipoprotein cholesterol 
(LDL-C). We identified partial correlation coefficients 
(r) between the lipids. Multiple linear regressions were 
performed to identify the amount of change in adolescents’ 
lipid levels for each unit increase of their mothers’ 
lipids. The regression models included various clinical 
characteristics and health behavioural factors of both 
adolescents and mothers.
results The mean levels of adolescents’ lipids were 
156.6, 83.6, 50.4 and 89.4 mg/dL, respectively for TC, 
TG, HDL-C and LDL-C. Positive correlations between lipid 
levels of adolescents and mothers were observed for TC, 
TG, HDL-C and LDL-C (r, 95% CI: 0.271, 0.236 to 0.304; 
0.204, 0.169 to 0.239; 0.289, 0.255 to 0.322; and 0.286, 
0.252 to 0.319). The adolescent TC level was increased 
by 0.23 mg/dL for each unit increase of the mother’s TC 
(SE, 0.02; p<0.001). The beta coefficients were 0.16 (SE, 
0.01), 0.24 (SE, 0.02) and 0.24 (SE, 0.02), respectively, in 
each model of TG, HDL-C and LDL-C (all p<0.001). The 
linear relationships were significant regardless of sex and 
mother's characteristics.
Conclusions Mothers’ lipid levels are associated 
with adolescents’ lipids; therefore, they can serve as a 
reference for the screening of adolescent’s dyslipidaemia.
IntrODuCtIOn   
Dyslipidaemia is a well-known risk factor for 
cardiovascular disease (CVD) in individuals of 
all ages.1 In Korea, CVD is the second-leading 
cause of death after cancer.2 Triglyceride (TG) 
and high-density lipoprotein cholesterol 
(HDL-C) are the major components of meta-
bolic syndrome (MetS). Likewise, the TG-to-
HDL-C ratio, a predictor for small, dense, 
low-density lipoprotein cholesterol (LDL-C), 
is an independent determinant of arterial 
stiffness in adolescents and young adults3 
which can subsequently accelerate athero-
sclerosis and increase cardiovascular events 
in the second decade of life.4 Meanwhile, 
lipid level is strongly linked to the body mass 
index (BMI) which is one of the reliable indi-
cators for obesity in adolescents.5 Paediatric 
obesity is affected by various family settings 
such as eating habits, lifestyle and education.6 
The prevalence of paediatric obesity in South 
Korea has been increasing rapidly from 5.8% 
in 1997 to 11.5% in 2014,7 which is close to 
the 13.3% in the USA.8 This has increased 
interest in obesity-related disorders in adoles-
cents, such as metabolic, cardiovascular and 
psychosocial complications.9 Obesity and 
dyslipidaemia are no longer the problems of 
adults alone; therefore, adequate screening 
and control of dyslipidaemia in adolescents 
has become important in South Korea.
strengths and limitations of this study
 ► This study analysed the linear relationships between 
lipid profiles of adolescents and their mothers using 
a large national database.
 ► We used survey-based statistical analyses, based 
on the design-effect related to survey sampling.
 ► Various health behavioural factors of adolescents 
and mothers were adjusted.
 ► There is no causal relationship as this was a 
cross-sectional study.
 ► The study did not provide any information on nutri-
tional factors which could be significant confounders.
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In addition to obesity, various factors such as physical 
activity, economic status, education level, nutritional and 
dietary factors, sleep duration and psychiatric problems, 
among others, have been associated with lipid concen-
tration.10–12 Meanwhile, family histories usually provide 
important information regarding paediatric diseases.13 
Regarding the highly heritable traits of dyslipidaemia, 
several studies showed that there was a close relation-
ship between the lipid concentrations of parents and 
their offsprings.14–16 This familial clustering implies that 
there may be common denominators, including health 
behavioural factors within a family, as well as genetic back-
grounds. In the present study, we investigated clinical and 
health behavioural factors affecting adolescents’ lipid 
levels, and evaluated the association between the lipid 
profiles of adolescents and their mothers.
MethODs
Data source
This is a cross-sectional study using the secondary data 
of the Korea National Health and Nutrition Examination 
Survey (KNHANES). KNHANES is an ongoing surveil-
lance system conducted by Korea Centers for Disease 
Control and Prevention (KCDC) since 1998 that assesses 
health and nutrition status, and monitors health risk 
factors and the prevalence of chronic diseases.17 A special 
survey team visits four regions every week (192 regions 
per year) and conducts a health examination, health 
interview and nutrition survey. This survey includes a 
representative sample of the population selected using 
a stratified, multi-stage and clustered sampling method. 
Sampling units are district, survey area and household. 
Stratification variables are city/province, district and 
housing type. The sample is weighted to reflect sampling 
rate, response rate and population demographics in 
order to estimate health consciousness, health behaviour 
and nutritional status for the population.
Among 59 015 individuals who were surveyed in 
KNHANES between 2009 and 2015, we selected 4148 
adolescents aged 12–18 years with available lipid profile 
data. Next, we obtained data for the mothers of these 
adolescents during the same survey period by matching 
household identification numbers. After the exclusion of 
1264 individuals with missing information about adoles-
cent’s or mother’s baseline characteristics or clinical 
findings, 2884 adolescents were eligible for the study 
(figure 1).
Outcome variables and health behavioural factors
Both adolescents' and mothers' lipid profiles consisted 
of total cholesterol (TC), TG, HDL-C and LDL-C. 
Outcome variables in the study were adolescents’ lipid 
levels. Mothers’ lipid levels, which represent genetic 
linkage, were the interesting variables. In order to 
examine their relationship, we adjusted various clin-
ical and health behavioural factors of both adolescents 
and mothers. The level of LDL-C was calculated using 
the Friedewald equation. If the TG level was 400 mg/
dL or more, measurement of LDL-C was performed by 
using the immunochemical method. Adolescents were 
divided into two age-groups based on whether they were 
high school students. In terms of obesity, we divided the 
study subjects into two groups using 85% cut-off of the 
body mass index (BMI) based on the age-groups and 
sex for adolescents, and divided them into three groups 
(<23, 23–24.9, ≥25 kg/m2) for mothers.18 19 The values of 
fasting glucose were also divided into two groups based 
on the level of impaired fasting glucose (≥100 mg/dL). 
Degree of stress was divided into three groups based on 
individuals’ perception. In addition, frequency of eating 
out, walking and exercise per week were investigated for 
adolescent health behaviours.
For mothers’ variables, we used data regarding smoking 
and alcohol habits, degree of education and family 
income, economic activity and frequency of eating out 
per week. Mother’s dyslipidaemia was defined based on 
TC level of 240 mg/dL or more, and included cases of 
individuals diagnosed or treated with dyslipidaemia even 
if the TC level was normal.
statistical methods
Lipid profiles were analysed as continuous variables with 
mean and SD in both adolescents and their mothers. We 
checked whether the continuous variables were normally 
distributed, and used a log-scale depending on the 
results. Independent sample t-tests or one-way analysis 
of variances was used for categorical independent vari-
ables to analyse the relationship with adolescents’ lipid 
levels. The correlation of lipid levels between adolescents 
and their mothers was analysed using partial correlations 
(r) with 95% CI. The r values were interpreted as slight 
(>0–0.2), fair (>0.2–0.4), moderate (>0.4–0.6), substan-
tial (>0.6–0.8) and almost perfect (>0.8). Next, multiple 
linear regressions with parameter estimates (beta coeffi-
cients) and SE were performed to identify the amount 
Figure 1 Study flow showing sample selection. We selected 
2884 adolescents aged 12–18 whose mothers’ data were 
also available.
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change in adolescents’ lipid levels for each unit increase 
of their mothers’ lipids. We used survey-based statis-
tical regression analyses, and the design-effect relating 
survey sampling was calculated. The regression models 
included clinical characteristics and health behavioural 
factors of both adolescents and mothers. In order to find 
the most adequate model fits  for 16 possible combina-
tions between four adolescents’ and their mothers’ lipid 
profiles, we calculated the adjusted R2 values, which repre-
sent the explanatory power of the model. In addition, the 
beta coefficients were also determined in the subgroups 
by sex and mother’s characteristics (age-group, BMI, 
degree of education, economic activity and presence or 
absence of dyslipidaemia) using multiple linear regres-
sion. Lastly, sensitivity test was done on 4148 adolescents 
including 1264 subjects who had inadequate baseline 
information or missing mothers’ data to identify the base-
line characteristics. All 2-sided p values <0.05 were consid-
ered significant. Statistical analyses were performed using 
SAS V.9.4 (SAS Institute, Cary, NC, USA).
Patient and public involvement
This study is a population-based survey study. Patients and 
public were not involved.
results
Table 1 shows baseline characteristics and their associ-
ations with adolescent lipid levels; p values were calcu-
lated considering log-transformed outcome values. The 
mean age of the study population was 14.7±1.9 years 
(range, 12–18 years), and 52.8% of the adolescents 
were male. A total of 9.3% of the individuals were over-
weight. The mean levels (ranges) of adolescents’ lipids 
were 156.6±27.0 (82–350), 83.6±46.4 (15– 602), 50.4±9.8 
(22–96) and 89.4±23.3 mg/dL (9–296), respectively, for 
TC, TG, HDL-C and LDL-C. HDL-C level was decreased 
in the older age-group (p=0.021). While TC, HDL-C and 
LDL-C levels were significantly higher in female adoles-
cents than in their male counterparts, TG was not different 
by sex. Individuals with increased BMI showed higher TC, 
TG and LDL-C levels, and lower HDL-C levels compared 
with those within the normal percentile range for BMI. 
The frequency of eating out was inversely associated with 
TC level (p=0.032), while increased frequency of walking 
was associated with decreased TC and LDL-C levels 
(p=0.006 and p=0.005, respectively). TG levels tended to 
increase in the adolescents whose mothers were obese 
(BMI ≥25 kg/m2), while the level of HDL-C was inversely 
associated with the mother’s BMI and increasing age. 
Other health behaviours of the mothers did not show any 
significant associations with their adolescents’ lipid levels.
Adolescent TC level demonstrated a fairly positive 
correlation with mother’s TC level (r, 0.271; 95% CI 
0.236 to 0.304) (online supplementary figure S1). TG, 
HDL-C and LDL-C levels also had fairly positive correla-
tions between adolescents and their mothers, yielding r 
(95% CI) 0.204 (0.169 to 0.239), 0.289 (0.255 to 0.322) 
and 0.286 (0.252 to 0.319), respectively. For refer-
ence, the correlations among the four adolescent lipid 
profiles demonstrated an almost perfect correlation 
between the TC and LDL-C levels (r, 0.915; 95% CI 0.909 
to 0.921; p<0.001), and showed a significant negative 
correlation between HDL-C and TG (r, −0.329; 95% CI 
−0.361 to −0.296; p<0.001). Meanwhile, the partial 
correlation coefficient (95% CI) for TC, TG, HLD-C and 
LDL-C was 0.254 (0.206 to 0.301), 0.235 (0.186 to 0.282), 
0.271 (0.224 to 0.317) and 0.267 (0.220 to 0.313) in 
male subjects (n=1522), and it was 0.291, (0.241 to 0.339), 
0.168, (0.116 to 0.220), 0.317 (0.268 to 0.364), and 0.309 
(0.260 to 0.357) in female subjects (n=1362). All p values 
were <0.001.
Based on the adjusted R2 values, the four most adequate 
regression models were selected (online supplementary 
table S1). Table 2 displays the multiple linear regressions 
of the four adequate models. It appears that p values are in 
log scale. The design-effect from survey sampling was 1.01, 
1.43, 1.07 and 1.07 in TC, TG, HDL-Cand LDL-C respec-
tively. Adolescent TC increased by 0.23 mg/dL on average 
as their mothers’ TC increased by 1 mg/dL (SE, 0.02, 
p<0.001). The beta coefficients were 0.16 (SE, 0.01), 0.24 
(SE, 0.02) and 0.24 (SE, 0.02), respectively, in each model 
of TG, HDL-Cand LDL-C (all p<0.001). TC increased by 
13.32 mg/dL in female adolescents compared with their 
male counterparts; other lipid parameters were also 
higher in female adolescents compared with their male 
counterparts. BMI had a positive association with the levels 
of TC, TG and LDL-C, while HDL-C was negatively associ-
ated with BMI. The frequency of eating out and walking 
tended to be inversely associated with TC and LDL-C. 
Exercise for more than 3 days per week was associated 
with increased TC and LDL-C levels compared with no 
exercise. With regard to mother’s variables, overall adoles-
cents’ lipid levels tended to decrease as their mothers’ 
age increased, and other lipids apart from HDL-C tended 
to decrease when the mother’s BMI increased. Mothers’ 
increased alcohol consumption was also significantly 
associated with adolescents’ decreased HDL-C. Mothers’ 
education, working hours, frequency of eating out and 
family income did not affect adolescent lipid levels.
Figure 2 represents the amount of change in adoles-
cents’ lipid levels with each unit increase in mothers’ lipids 
in the subgroups. In most subgroups, there were signifi-
cant positive relationships between lipids in adolescents 
and mothers, with the exception of subgroups with rela-
tively small sample sizes (table 3). The beta  coefficients 
of TC, HDL-C and LDL-C were high in female adoles-
cents compared with their male counterparts, whereas 
that of TG was higher in the male adolescents. When 
the lipid profiles were considered as binary outcomes, 
multivariate logistic regressions showed that adolescents’ 
dyslipidaemia was significantly associated with mothers’ 
dyslipidaemia (online supplementary table S2). Finally, 
the sensitivity test on 4148 adolescents showed compa-
rable baseline characteristics with our study data (online 
supplementary table S3).
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DIsCussIOns
There is significance in that our study analysed linear 
relationships of TC, TG, HDL-C and LDL-C, respectively, 
with the amount change in adolescents’ lipid levels for 
each unit increase in their mothers’ lipids. We adjusted 
for various health behavioural factors of adolescents and 
their mothers, as well as used a large national database. 
Moreover, we found that relationships between lipids of 
adolescents and their mothers were significant regardless 
of sex and mother's characteristics.
Atherosclerosis is triggered by childhood obesity asso-
ciated with lipid abnormalities, rather than by obesity 
itself.20 The prevalence of dyslipidaemia was 6.5% in 
Korea by the cut-off of National Cholesterol Education 
Programme and American Heart Association guidelines.21 
Meanwhile, the most frequent components among five 
MetS criteria in adolescence were high TG (21.2%) and 
low HDL-C (13.6%).22 When cut-off values of a recent 
guideline were applied to our data,23 the percentages of 
abnormal TC (≥200 mg/dL), TG (≥130 mg/dL), HDL-C 
(<40 mg/dL) and LDL-C (≥130 mg/dL) were 6.6%, 
11.9%, 13.3% and 5.0%, respectively. Atherogenic dyslipi-
daemia, characterised by the combination of high TG and 
small dense LDL-C and low HDL-C, was a common form 
of dyslipidaemia in young individuals (aged, 2–18 years) 
and had a strong familial aggregation.24 Even taking into 
consideration the argument that a higher cut-off level 
of TG (≥150 mg/dL) is appropriate for Korean adoles-
cents,25 the rate of high TG observed in the present study 
was 7.7%. That is, our data showed, a more considerable 
proportion of abnormal TG and HDL-C in adolescents 
compared with other lipid parameters. Thus, the present 
study provides further evidence that dyslipidaemia, espe-
cially atherogenic dyslipidaemia, is a big problem in 
Korean adolescents, with the concern that it leads to CVD 
during the remainder of the lifespan.
It has been reported that dyslipidaemia was associ-
ated with increased odds of dyslipidaemia in first-degree 
relatives (OR=2.2).26 This familial clustering is, in turn, 
caused by both genetic backgrounds and shared environ-
mental factors within a family. A previous study found 
that genes contribute more than the environment to 
familial correlation of lipids and obesity.15 In this regard, 
numerous genetic determinants regulating lipid concen-
trations have been investigated.27 In addition, an animal 
study demonstrated that maternal dyslipidaemia affected 
the offspring’s lipid levels by activation of endogenous 
cholesterol synthesis.28 Whatever the cause or, a family 
history must be a major risk factor for adolescent’s dyslip-
idaemia. Meanwhile, even in the subgroup of mothers 
who had normal TC levels and had never been diagnosed 
with dyslipidaemia, the positive relationships in lipids 
between the adolescents and their mothers were signifi-
cant for all lipid parameters. These findings may reflect 
environmental impacts such as healthy diet, exercise 
habits, and efforts to improve lifestyles within families, 
rather than just a hereditary influence. Of course, there 
may also be an impact from other genetic factors such as 
diabetes or hypertension in first-degree relatives.26 Inter-
estingly, the beta coefficient was higher in adolescents 
with non-obese mothers compared with those with obese 
mothers. It is possible that the genetic background of 
Figure 2 Bar graphs showing standardised beta coefficients of adolescents' lipids for each unit increase in their mothers' 
lipids in subgroups. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein 
cholesterol; TC, total cholesterol; TG, triglyceride.
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non-obese dyslipidemic mothers affected the lipid levels 
of their offspring. However, the mean BMI of dyslipid-
emic mothers was higher than that of non-dyslipidemic 
mothers (24.7 kg/m2 vs 23.2 kg/m2). Moreover, the beta 
coefficient was also higher in adolescents with non-dyslip-
idemic mothers than in those with dyslipidemic mothers. 
Thus, it is more likely that the mothers’ perception  of 
dyslipidaemia influences the adolescents’ lipid levels. Of 
course, this interpretation requires consideration of rela-
tionship between lipids and characteristics in mothers. 
Awareness of dyslipidaemia was relatively low despite its 
higher prevalence worldwide.29 A mother’s perception 
of lipid levels could affect her children’s lipids through 
efforts related to lifestyle and diet changes.30 A recent 
Korean study highlighted education and counselling in 
order to change health behaviour in addition to aware-
ness of dyslipidaemia.31 Our results from subgroup anal-
yses support these previous studies and highlight the 
influence of the mother’s perception of dyslipidaemia 
and resultant lifestyle changes.
There is no doubt that lifestyle modification plays a 
central role in lipid control. Moreover, considering the 
high rates of abnormal TG and HDL-C and the restricted 
indications of lipid-lowering agents in youth, lifestyle 
changes should play a larger role in adolescent patients. 
Our results showed that frequent walking was negatively 
associated with TC and LDL-C levels, which is predict-
able. Meanwhile, frequent eating out was associated with 
decreased TC and LDL-C, a finding that conflicts with 
the general notion that eating out induces a high calorie 
intake or overeating. Eating out was defined as all foods 
except home-cooked dishes in this survey, thus  including 
school meals as well as dining out and delivery foods. 
Actually, the frequency of eating out showed a great 
discrepancy between adolescents and mothers in this 
study. Thus, school foods may compensate for negative 
effects of eating out by providing regular and well-bal-
anced meals. The positive correlation between exer-
cise and lipid levels, which is also an unexpected result, 
seems to be influenced by exercise intensity. Exercise 
frequency alone was not sufficient to explain the effect 
of exercise adequately; thus, the strength and duration 
of exercise should be considered. Our data regarding 
health behavioural factors should be more detailed and 
concrete. However, it is certain that health behavioural 
habits influence the lipid levels of adolescents, and there-
fore adolescents with dyslipidaemia and their families 
should be encouraged to improve their lifestyles.
Cholesterol levels in children and adolescents are 
highly dependent on age and sex.32 Our data showed 
that the levels of TC, LDL-C and HDL-C were higher 
in female adolescents that in males. In addition, the 
beta coefficients per unit increase of mother’s TC, LDL-C 
and HDL-C were also prominent in female subjects. It is 
possible that mothers with female offspring are either 
more obese and dyslipidemic or otherwise. However, 
mother’s mean BMI was similar between male and female 
adolescents (23.3 ± 3.2 and 23.5 ± 3.3 kg/m2, respectively, 
p=0.161); furthermore, the rate of mother’s dyslipidaemia 
showed no statistical difference between male and female 
adolescents (10.8% vs 9.8%, respectively, p=0.373). Thus, 
the difference in beta  coefficient by sex may be due to a 
distinct difference in lipid levels by sex. This is supported 
by our result that the TG level was higher in male than 
in female adolescents and the  beta coefficient of TG was 
also higher in male adolescents.
This study has several limitations. First, because it is 
a survey-based study, our data are vulnerable to recall 
bias. Second, as it is a cross-sectional design, there was 
no causal relationship. This factor will be particularly 
important in consideration of the impacts due to envi-
ronmental factors. Further well-designed cohort studies 
are warranted. Third, individuals who responded to the 
national survey could have greater health concerns. 
They may have better health behavioural habits or family 
members with chronic diseases. However, this survey 
was uniformly performed in all regions of Korea and 
targeted all age-groups; thus, our data can be considered 
nationally representative. Fourth, the nutritional factors, 
which were not considered in the analyses because of 
insufficient information and large missing values, can be 
significant confounding factors. Further studies based 
on detailed surveys for health behavioural factors and 
nutritional elements are needed. Fifth, we did not eval-
uate the father’s lipid levels. If the father’s lipid levels had 
also been considered, the genetic backgrounds of lipids 
might be emphasised more. Sixth, various comorbidities 
such as hypothyroidism, Cushing’s disease, liver disease 
and nephrotic syndrome, among others, as well as long-
term use of steroid can affect lipid level,33 and these could 
be also confounding factors. However, these chronic 
diseases are extremely rare during the adolescent period, 
and thus could be negligible. Finally, the results of our 
study need to be evaluated with caution as they might be 
vulnerable to family-wise type I error due to the multiple 
tests involved in our analysis. However, even considering 
this, the p values for the associations are sufficiently 
significant. Additionally, R2 indicates just how well the 
model explains variability of the response data. Although 
we chose four models, which showed high R2, it does not 
mean accurate representation of goodness of fit for the 
models.
In conclusion, a mother’s lipid levels were positively 
associated with her adolescents’ lipid levels because of 
both genetic and environmental factors within the family. 
Adolescent dyslipidaemia creates a large risk factor 
burden for cardiovascular diseases; therefore, timely 
screening for dyslipidaemia is important, especially for 
indicated adolescents. Our positive correlation between 
lipids of adolescents and their mothers supports that the 
mother’s lipid level is an appropriate reference for the 
screening of the adolescent’s dyslipidaemia.
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